• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样变性相关性肾病

Amyloidosis-associated kidney disease.

作者信息

Dember Laura M

机构信息

Renal Section, Boston University School of Medicine, EBRC 504, 650 Albany Street, Boston, MA 02118, USA.

出版信息

J Am Soc Nephrol. 2006 Dec;17(12):3458-71. doi: 10.1681/ASN.2006050460. Epub 2006 Nov 8.

DOI:10.1681/ASN.2006050460
PMID:17093068
Abstract

The amyloidoses are a group of disorders in which soluble proteins aggregate and deposit extracellularly in tissues as insoluble fibrils, causing progressive organ dysfunction. The kidney is one of the most frequent sites of amyloid deposition in AL, AA, and several of the hereditary amyloidoses. Amyloid fibril formation begins with the misfolding of an amyloidogenic precursor protein. The misfolded variants self-aggregate in a highly ordered manner, generating protofilaments that interact to form fibrils. The fibrils have a characteristic appearance by electron microscopy and generate birefringence under polarized light when stained with Congo red dye. Advances in elucidating the mechanisms of amyloid fibril formation, tissue deposition, and tissue injury have led to new and more aggressive treatment approaches for these disorders. This article reviews the pathogenesis, diagnosis, clinical manifestations, and treatment of the amyloidoses, focusing heavily on the renal aspects of each of these areas.

摘要

淀粉样变性是一组疾病,其中可溶性蛋白质聚集并以不溶性纤维的形式在组织细胞外沉积,导致进行性器官功能障碍。肾脏是AL、AA及几种遗传性淀粉样变性中淀粉样蛋白沉积最常见的部位之一。淀粉样纤维的形成始于淀粉样前体蛋白的错误折叠。错误折叠的变体以高度有序的方式自我聚集,产生原丝,原丝相互作用形成纤维。这些纤维在电子显微镜下具有特征性外观,用刚果红染料染色后在偏振光下产生双折射。在阐明淀粉样纤维形成、组织沉积和组织损伤机制方面的进展,已导致针对这些疾病的新的、更积极的治疗方法。本文综述了淀粉样变性的发病机制、诊断、临床表现及治疗,重点关注这些领域中每个方面的肾脏问题。

相似文献

1
Amyloidosis-associated kidney disease.淀粉样变性相关性肾病
J Am Soc Nephrol. 2006 Dec;17(12):3458-71. doi: 10.1681/ASN.2006050460. Epub 2006 Nov 8.
2
[Renal amyloidosis].[肾淀粉样变性]
Przegl Lek. 2013;70(4):205-10.
3
Hereditary systemic amyloidosis with renal involvement.伴有肾脏受累的遗传性全身性淀粉样变性
J Nephrol. 2003 May-Jun;16(3):443-8.
4
[Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].[形成原纤维的蛋白质:淀粉样变性。心脏病专家必须了解的一种疾病的新希望]
Ital Heart J Suppl. 2002 Jun;3(6):590-7.
5
[Advances in diagnosis and treatment of AL amyloidosis].[AL淀粉样变性的诊断与治疗进展]
Pol Merkur Lekarski. 2008 Apr;24(142):340-5.
6
Pathogenesis, diagnosis and treatment of systemic amyloidosis.系统性淀粉样变性的发病机制、诊断与治疗
Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):203-10; discussion 210-1. doi: 10.1098/rstb.2000.0766.
7
[Systemic AA amyloidosis induced by benign neoplasms].[良性肿瘤诱发的系统性AA型淀粉样变性]
Nefrologia. 2008;28(1):93-8.
8
[Amyloidosis and renal failure].[淀粉样变性与肾衰竭]
Recenti Prog Med. 1999 Oct;90(10):530-5.
9
Cardiac amyloidosis: approaches to diagnosis and management.心脏淀粉样变性:诊断与治疗方法。
Cardiol Rev. 2010 Jan-Feb;18(1):1-11. doi: 10.1097/CRD.0b013e3181bdba8f.
10
[Differential diagnosis of amyloidosis].[淀粉样变性的鉴别诊断]
Verh Dtsch Ges Pathol. 2002;86:107-15.

引用本文的文献

1
Therapeutic potential of cultivated with seeds for alleviating western diet-induced type 2 diabetes and diabetic nephropathy.用种子培育的[物质]对缓解西方饮食诱导的2型糖尿病和糖尿病肾病的治疗潜力。 (注:原文cultivated with后面似乎缺少关键信息,这里按推测补充了[物质],以便译文相对完整通顺)
Front Pharmacol. 2025 May 29;16:1562116. doi: 10.3389/fphar.2025.1562116. eCollection 2025.
2
Epidemiology and clinical presentation of kidney amyloidosis have changed over the past three decades: a nationwide population-based study.过去三十年中肾淀粉样变性的流行病学及临床表现发生了变化:一项基于全国人口的研究
BMC Nephrol. 2025 Jun 2;26(1):272. doi: 10.1186/s12882-025-04136-w.
3
Validation of a renal staging system and its association with renal amyloid deposition burden in AL amyloidosis.
一种肾脏分期系统的验证及其与AL型淀粉样变性中肾脏淀粉样蛋白沉积负荷的关联
Ren Fail. 2025 Dec;47(1):2499230. doi: 10.1080/0886022X.2025.2499230. Epub 2025 May 19.
4
Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update.具有肾脏意义的单克隆丙种球蛋白病(MGRS)的诊断与治疗进展:最新综述
Diagnostics (Basel). 2024 Dec 23;14(24):2892. doi: 10.3390/diagnostics14242892.
5
Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis.替西他单抗在复发或难治性AL淀粉样变性患者中的安全性和有效性
Eur J Haematol. 2025 Mar;114(3):443-447. doi: 10.1111/ejh.14348. Epub 2024 Nov 17.
6
Linking Environmental Genotoxins to Neurodegenerative Diseases Through Transcriptional Mutagenesis.通过转录诱变将环境遗传毒素与神经退行性疾病联系起来。
Int J Mol Sci. 2024 Oct 24;25(21):11429. doi: 10.3390/ijms252111429.
7
Transcript errors generate amyloid-like proteins in huwman cells.转录错误导致人类细胞产生淀粉样蛋白。
Nat Commun. 2024 Oct 7;15(1):8676. doi: 10.1038/s41467-024-52886-2.
8
Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes.推进肾脏淀粉样变性病的护理:现代诊断技术的作用及其改善患者预后的潜力。
Int J Mol Sci. 2024 May 28;25(11):5875. doi: 10.3390/ijms25115875.
9
Secondary amyloidosis in inflammatory bowel disease patients: findings from three tertiary medical centers.炎症性肠病患者的继发性淀粉样变性:来自三个三级医疗中心的研究结果。
Clin J Gastroenterol. 2024 Oct;17(5):844-853. doi: 10.1007/s12328-024-02003-z. Epub 2024 Jun 16.
10
Effect of Tafamidis on Renal Function in Patients With Transthyretin Amyloid Cardiomyopathy in ATTR-ACT.在ATTR-ACT研究中,他法米地斯对转甲状腺素蛋白淀粉样心肌病患者肾功能的影响。
JACC CardioOncol. 2024 Apr 16;6(2):300-306. doi: 10.1016/j.jaccao.2024.02.007. eCollection 2024 Apr.